After a recent reevaluation of the Monolisa anti-HBs EIA package insert, the CTS QA/Scientific team is changing the acceptable shipping conditions for samples requiring this test. Effective immediately, samples requiring Monolisa anti-HBs EIA testing must be shipped directly to Special Testing in CTS Phoenix at 2-8 C using wet ice or frozen using dry ice.
Samples submitted to CTS in the routine donor sample shipper will be deemed unacceptable for the Monolisa anti-HBs EIA test. If you have questions, contact your Customer Service Manager.
On December 28, 2021, the FDA updated the emergency use authorization (EUA) for COVID-19 conva...
Reminder - On Wednesday June 6, 2018 at 10:00AM PST, we will be hosting a webinar regarding the chan...
Dr. Buff Mair is the new CTS Medical Director and replaces Dr. German Leparc who retired at the begi...
On January 25, 2021, CTS implements the Ortho VIP viral marker testing platform. Conversion from the...
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
On December 9, 2019, the new CTS Laboratory Information System successfully implemented in Phoe...